Phio Pharmaceuticals Corp (PHIO)

$1.01 -0.01 (-0.98%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	10.98M
Revenue (ttm)	0.00
Net Income (ttm)	-7.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	461,600
Avg Vol	4,599,156
Day's Range	N/A - N/A
Shares Out	10.76M
Stochastic %K	11%
Beta	0.90
Analysts	Sell
Price Target	$14.00

Company Profile

Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma a...

Industry: Biotechnology

Sector: Healthcare

Phone: 508 767 3861

Website: phiopharma.com

Address:

11 Apex Drive, Suite 300A PMB 2006, Marlborough, United States

OfficialStocktwitsUser Mar. 3 at 6:23 PM

$PHIO RSI: 47.20, MACD: -0.0121 Vol: 0.19, MA20: 1.10, MA50: 1.09 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

STEEZY_TRADES Mar. 3 at 5:04 PM

$PHIO wait for it you infadels

1 · Reply

DosGatos Mar. 3 at 2:45 PM

$PHIO Where is the pump crew?!

0 · Reply

DosGatos Mar. 2 at 2:48 PM

$PHIO

2 · Reply

DERDER Mar. 1 at 11:19 PM

$PHIO

0 · Reply

trader_23 Mar. 1 at 4:22 AM

$PHIO

0 · Reply

Rod75b15 Feb. 26 at 1:07 PM

$PHIO It's just a matter of time—I have no idea if it's a matter of weeks or a few months—but it will return to nearly $9, like in January 2025, when it started at $1.50. Personally, from 2023 to today, I've made excellent profits with Phio several times, and I'm very satisfied with their results and goals.

0 · Reply